Fig. 10: MDS analysis of ATP2B2-Gaultherin/MSTG-A/MSTG-B complex at 100 ns. | Schizophrenia

Fig. 10: MDS analysis of ATP2B2-Gaultherin/MSTG-A/MSTG-B complex at 100 ns.

From: Exploration on the potential efficacy and mechanism of methyl salicylate glycosides in the treatment of schizophrenia based on bioinformatics, molecular docking and dynamics simulation

Fig. 10

A RMSD curve of ATP2B2-Gaultherin/MSTG-A/MSTG-B complex. B RMSD curve of Gaultherin, MSTG-A and MSTG-B. C Rg curve of ATP2B2-Gaultherin/MSTG-A/MSTG-B complex. D SASA curve of ATP2B2-Gaultherin/MSTG-A/MSTG-B. E The number of hydrogen bonds of ATP2B2-Gaultherin/MSTG-A/MSTG-B complex. F RMSF plot of ATP2B2-Gaultherin/MSTG-A/MSTG-B complex. G–I The amino acid breakdown of ATP2B2-Gaultherin/MSTG-A/MSTG-B complex.

Back to article page